| ORIGINAL ARTICLE |
|
| Year : 2023 | Volume
: 66
| Issue : 1 | Page : 81-84 |
|
|
Study of growth differentiation factor-15 in polytransfused children with β-thalassemia
Swati Meena1, Kusha Sharma1, Sunita Sharma1, Jagdish Chandra2
1 Department of Pathology, Lady Hardinge Medical College and Associated SSK and KSC Hospitals, New Delhi, India
2 Department of Paediatrics, KSCH and Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
Correspondence Address:
Kusha Sharma
C-2/2001, Vasant Kunj, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijpm.ijpm_803_21
|
|
|
Background: Ineffective erythropoiesis is a predominant feature in β-thalassemia major (β-TM), causing marked erythroid expansion leading to highly raised levels of growth differentiation factor-15 (GDF-15), which, in turn, suppresses hepcidin production in liver resulting in increased iron absorption from gut. We aim to study the serum GDF-15 in polytransfused β-TM patients and its correlation with serum ferritin and serum hepcidin. Method: Thirty-nine polytransfused β-TM children aged between 5 and 17 years and 33 age- and gender-matched healthy controls were enrolled in the study. Complete blood count, serum GDF-15, serum ferritin, and serum hepcidin were performed. Results: The mean serum GDF-15, serum hepcidin, and serum ferritin levels were 638.65 ± 306.96 pg/ml, 108.21 ± 191.30 ng/ml, and 2274.60 ± 1216.08 ng/ml, respectively, which were significantly higher than control group (P < 0.001, P = 0.003, P < 0.001, respectively). There was significant positive correlation of GDF-15 with blood transfusions (r = 0.415, P = 0.009), positive correlation with serum ferritin (r = 0.653, P = 0), and significant negative correlation with serum hepcidin (r = −0.508, P = 0.001). Conclusion: The findings of the present study suggest that GDF-15 is an important regulator of hepcidin in β-TM patients. GDF-15 and serum hepcidin together can be used to monitor iron overload and its related complications in such patients.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
